TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science February 26, 2010
TCL Archive In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center December 7, 2012
TCL Archive DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done November 5, 1982
